1. Home
  2. MHK vs HALO Comparison

MHK vs HALO Comparison

Compare MHK & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mohawk Industries Inc.

MHK

Mohawk Industries Inc.

N/A

Current Price

$102.98

Market Cap

6.6B

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$63.85

Market Cap

8.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MHK
HALO
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
8.8B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
MHK
HALO
Price
$102.98
$63.85
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$137.78
$78.18
AVG Volume (30 Days)
947.1K
1.8M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.93
2.56
Revenue
N/A
$151,862,000.00
Revenue This Year
$3.53
$28.24
Revenue Next Year
$3.10
$12.79
P/E Ratio
$17.97
$26.00
Revenue Growth
N/A
N/A
52 Week Low
$96.24
$47.50
52 Week High
$143.13
$82.22

Technical Indicators

Market Signals
Indicator
MHK
HALO
Relative Strength Index (RSI) 24.81 29.05
Support Level $97.42 $63.85
Resistance Level $116.52 $65.40
Average True Range (ATR) 4.20 1.85
MACD -2.30 -0.67
Stochastic Oscillator 0.53 1.18

Price Performance

Historical Comparison
MHK
HALO

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: